HKMPF News and Press, Hikma Pharmaceuticals Plc From 04/28/21

Hikma Pharmaceuticals ([[HKMPF]] -2.1%) has signed an exclusive license and distribution agreement with AFT Pharmaceuticals for the commercialisation of Combogesic IV, an intravenous, opioid free post-operative pain relief medicine.The licensing agreement provides Hikma with exclusi...

Hikma Pharmaceuticals (HKMPF) has resumed the launch of its generic version of GlaxoSmithKline's blockbuster asthma treatment Advair Diskus in the United States.The launch follows US FDA approval of an amendment Hikma submitted to its Abbreviated New Drug Application ((ANDA)) in January ...

Hikma resumes launch of generic Advair Diskus® PR Newswire LONDON , April 20, 2021 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that it has resumed the launch of its generic version of ...

GlaxoSmithKline (GSK), the majority shareholder of GSK Egypt with 91% ownership, has rejected an acquisition offer for its assets in Egypt from Jordan-based, Arab Company for Drug Industries & Medical Appliances (ACDIMA).In February, GSK Egypt announced through a regulatory fili...

The following slide deck was published by Hikma Pharmaceuticals PLC in conjunction with their 2020 Q4 earnings call. For further details see: Hikma Pharmaceuticals PLC 2020 Q4 - Results - Earnings Call Presentation

Hikma Pharmaceuticals (HKMPF) has confirmed that it is in talks with GlaxoSmithKline S.A.E. (GSK SAE), the listed Egyptian subsidiary within the GlaxoSmithKline (GSK), for a potential acquisition of GSK’s assets in Egypt and Tunisia.Noting disclosure made today to the Egyptia...

My net worth went up ~ 40% this year. Facebook is my second largest position at 22% of my portfolio. Interactive Brokers is my third largest position at 18% of the portfolio. For further details see: Reflections 2020

LONDON , Sept. 3, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that the US Court of Appeals for the Federal Circuit today upheld a ruling by the US District Court for the District of Nevada finding that Hikma's gen...

Hikma Pharmaceuticals PLC (HKMPF) Q2 2020 Earnings Conference Call August 7, 2020 3:00 AM ET Company Participants Siggi Olafsson - CEO Khalid Nabilsi - CFO Presentation Siggi Olafsson Hello, everyone. I'm Siggi Olafsson, CEO of Hikma Pharmaceuticals, and I'm here with Kh...

Hikma Pharmaceuticals ( OTCPK:HKMPF ) : 1H Non-GAAP EPS of $0.853; GAAP EPS of $0.876. More news on: Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals PLC, Earnings news and commentary, Healthcare stocks news, Read more ...